APA (7th ed.) Citation

Geretti, A. M., White, E., Orkin, C., Tostevin, A., Tilston, P., Chadwick, D., . . . Dunn, D. T. (2019). Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance. Journal of antimicrobial chemotherapy, 74(3), 746-753. https://doi.org/10.1093/jac/dky468

Chicago Style (17th ed.) Citation

Geretti, Anna Maria, Ellen White, Chloe Orkin, Anna Tostevin, Peter Tilston, David Chadwick, Clifford Leen, Caroline Sabin, and David T. Dunn. "Virological Outcomes of Boosted Protease Inhibitor-based First-line ART in Subjects Harbouring Thymidine Analogue-associated Mutations as the Sole Form of Transmitted Drug Resistance." Journal of Antimicrobial Chemotherapy 74, no. 3 (2019): 746-753. https://doi.org/10.1093/jac/dky468.

MLA (9th ed.) Citation

Geretti, Anna Maria, et al. "Virological Outcomes of Boosted Protease Inhibitor-based First-line ART in Subjects Harbouring Thymidine Analogue-associated Mutations as the Sole Form of Transmitted Drug Resistance." Journal of Antimicrobial Chemotherapy, vol. 74, no. 3, 2019, pp. 746-753, https://doi.org/10.1093/jac/dky468.